Cancer Drug Recalled Due to Visible Particles in Glass Vials

Hospira notified healthcare professionals of a nationwide recall of four injectable cancer drugs due to concerns that particles located in the glass at the neck of the vial may dislodge and come in contact with the medications.

The drugs included in the recall are carboplatin, cytarabine, paclitaxel, and methotrexate, according to the Food and Drug Administration.

If the particulate matter were injected into the patient’s body, it could potentially cause injuries which might require medical attention, with symptoms such as bleeding, bruising, inflammation, itching, rash, chest pain, and respiratory symptoms.

Hospira says its investigations into the issue indicate a supplier defect in the glass used in the neck of the vials. The company says corrective and preventive actions have been identified and initiated. Hospira has not received any reports of adverse events related to the recalled drugs.

Hospira sent a letter about the recall to wholesalers and medical facilities that purchased the drugs directly from the company. The company is arranging for the return and replacement of the affected products.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you. For legal help, call (800) 581-6358.

Tags: